Studies by Li FF et al. have revealed a correlation between elevated levels of SHP2 and increased inflammatory markers in COPD, suggesting that selective inhibition or knockdown of SHP2 can reduce pulmonary inflammation [44]. Here, PTPN11 is linked to chronic obstructive pulmonary disease.